Replies to post #413 on Trevena Inc (TRVN)

[slystockhound]

Realistically it's a crap shoot on a political level... as with any pharmacological entity. The data that exists today (coming directly from the company) from what I've seen would give it a leg up on morphine (the standard) w/ a pretty substantial reduction in vomiting, constipation, as well as respiratory safety events. Additionally, it is cheaper than the current standard of care.

Not to mention, the current opioid situation, where this may be a suitable counter for the ongoing epidemic.

My two cents. I'm in with 50K shares @ 1.57.

[Curt D]

Check out this earlier post and read the article.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143643559

[Ocnswm]

The continual shortage of morphine/fentanyl, combined with the fact that Olinvo will be hospital use only I can't find a reason to vote no. Share price/volume when briefing documents are released will be a tell. GL